ArticleGeneral psychiatry2025
Depression preceding and following the diagnosis of Parkinson's disease and Lewy body dementia.
Article in General psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Depression and Mood Changes in People with Parkinson's Disease over Time: A 5-Year Follow-Up Study.Journal of personalized medicine · 2026Article
- Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective.Neuropsychiatric disease and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a common comorbidity in Parkinson's disease (PD) and Lewy body dementia (LBD). However, studies examining the rate of incident depression in the period preceding and following the diagnosis of PD and LBD are lacking in the literature. Aims: To quantify the incidence of depression in the period preceding and following the diagnosis of PD and LBD. Methods: We conducted a retrospective case-control study. Specifically, we used Danish registers to identify all patients with a diagnosis of PD or LBD in the period from 2007 to 2019. These patients were matched by age, calendar year of diagnosis and sex with up to three patients diagnosed with rheumatoid arthritis (RA), chronic kidney disease (CKD) or osteoporosis, respectively. The outcome was incident depression. The incidence of depression was assessed for up to 10 years before and up to 10 years after the diagnosis of PD or LBD. Hazard rates of incident depression for patients with PD or LBD, both before and after diagnosis, were compared with those for patients with RA, CKD or osteoporosis using a Cox-proportional hazards model. Results: We identified 17 711 patients with PD or LBD. Their median age was 74.98 (68.10-80.85) years, and 39.92% were females. These patients were matched to 19 556, 40 842 and 47 809 patients with RA, CKD and osteoporosis, respectively. From 7 to 8 years before diagnosis to 5 years after diagnosis, patients with PD and LBD consistently had higher hazard rates of incident depression than all comparator groups. Conclusions: These findings are compatible with depression being an early manifestation of the neurodegenerative changes eventually leading to PD and LBD and imply that incident depression at a late age should raise awareness of potential PD and LBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.